Renal Endothelin-1: Control of Sodium Excretion and Blood Pressure

肾内皮素-1:控制钠排泄和血压

基本信息

  • 批准号:
    8299352
  • 负责人:
  • 金额:
    $ 8.85万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-06-15 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): High blood pressure is a major public health problem worldwide leading to cardiovascular disease and death. The kidneys play a critical role in maintaining normal blood pressure by increasing salt excretion when dietary intake is elevated. Inappropriate salt retention by the kidneys results in hypertension. Understanding the mechanisms by which the kidneys eliminate excess salt will clarify the causes of hypertension and identify new approaches for treatment, extending patient's lives and improving their quality of life. Recent studies have shown that high salt intake increases production of the small peptide endothelin-1 within the kidney; however, its role in stimulating salt excretion in vivo is unknown. The overall goal of this proposal is to investigate how endothelin-1 causes the kidney to eliminate more salt during high salt feeding. Overall hypotheses to be tested are: 1) when dietary salt is elevated, endothelin-1 derived from the nephron acts as an autacoid, inhibiting salt reabsorption and promoting natriuresis; and 2) endothelin-1 also functions as a paracrine factor that acts on adjacent medullary interstitial cells to stimulate medullary blood flow and facilitate sodium excretion. Both mechanisms are crucial for high salt-induced natriuresis, and defects in this system will lead to salt retention and hypertension. These hypotheses will be tested using animals in which expression of individual genes is eliminated only in certain types of cells in the kidney, employing novel approaches that combine in vivo and in vitro technology. This application provides the foundation for a career development plan for Dr. Marcela Herrera, a cell/physiology-trained post-doctoral fellow committed to a research career in kidney disease and hypertension. The applicant will be mentored by Dr. Thomas Coffman at Duke University Medical Center, who will train the PI in generating transgenic animal models and using in vivo physiological techniques to study them. This proposal has been structured to provide complementary and substantive training opportunities. The applicant will gain expertise in mouse genetics, producing transgenic animals, and in vivo physiology. This will provide a solid basis for the trainee to develop a multi-disciplinary program of research using physiological, cellular/molecular, and genetic techniques to achieve her goal of becoming an independent investigator.
描述(由申请人提供):高血压是全球一个主要的公共卫生问题,导致心血管疾病和死亡。当饮食摄入量升高时,肾脏通过增加盐分排泄来维持正常血压。肾脏不适当的盐分会导致高血压。了解肾脏消除过量盐的机制将阐明高血压的原因,并确定新的治疗方法,延长患者的生活并改善其生活质量。最近的研究表明,高盐的摄入量增加了肾脏内肽内皮素-1的产生。但是,其在体内刺激盐排泄中的作用尚不清楚。 该提案的总体目标是研究内皮素-1如何导致肾脏在高盐喂养过程中消除更多的盐。总的总体假设是:1)当饮食中盐升高时,源自肾单位的内皮素-1是一种自闭症,可以抑制盐的吸收并促进Natriuresis; 2)内皮素-1还起作用的旁分泌因子,该因子作用于相邻的髓质间质细胞,以刺激髓样血流并促进钠排泄。这两种机制对于高盐引起的纳地尿症至关重要,并且该系统中的缺陷将导致盐保留和高血压。这些假设将使用动物进行测试,其中仅在肾脏中的某些类型的细胞中消除单个基因的表达,采用新型方法结合体内和体外技术。该申请为Marcela Herrera博士的职业发展计划奠定了基础,Marcela Herrera博士是由细胞/生理学培训的博士后研究员致力于从事肾脏疾病和高血压研究生涯的工作。申请人将由杜克大学医学中心的托马斯·科夫曼(Thomas Coffman)博士进行指导,杜克大学医学中心(Thomas Coffman)将培训PI生成转基因动物模型并使用体内生理技术来研究它们。该建议的结构是提供互补和实质性的培训机会。申请人将获得小鼠遗传学,产生转基因动物和体内生理学的专业知识。这将为学员提供使用生理,细胞/分子和遗传技术的多学科研究计划的扎实基础,以实现成为独立研究者的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Maria Marcela Herrera其他文献

Maria Marcela Herrera的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Maria Marcela Herrera', 18)}}的其他基金

Renal Endothelin-1: Control of Sodium Excretion and Blood Pressure
肾内皮素-1:控制钠排泄和血压
  • 批准号:
    8485655
  • 财政年份:
    2012
  • 资助金额:
    $ 8.85万
  • 项目类别:
Role of the kidneys in hypertension: paracrine actions of NO in the renal medulla
肾脏在高血压中的作用:肾髓质中 NO 的旁分泌作用
  • 批准号:
    7487606
  • 财政年份:
    2008
  • 资助金额:
    $ 8.85万
  • 项目类别:
Role of the kidneys in hypertension: paracrine actions of NO in the renal medulla
肾脏在高血压中的作用:肾髓质中 NO 的旁分泌作用
  • 批准号:
    7808018
  • 财政年份:
    2008
  • 资助金额:
    $ 8.85万
  • 项目类别:
Role of the kidneys in hypertension: paracrine actions of NO in the renal medulla
肾脏在高血压中的作用:肾髓质中 NO 的旁分泌作用
  • 批准号:
    7616540
  • 财政年份:
    2008
  • 资助金额:
    $ 8.85万
  • 项目类别:

相似海外基金

Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
处于癌症免疫治疗前沿的新兴细胞疗法
  • 批准号:
    10540496
  • 财政年份:
    2023
  • 资助金额:
    $ 8.85万
  • 项目类别:
The antigen specificity of tumor-targeting T cells in non-small cell lung cancer
非小细胞肺癌中肿瘤靶向T细胞的抗原特异性
  • 批准号:
    10590220
  • 财政年份:
    2023
  • 资助金额:
    $ 8.85万
  • 项目类别:
Reprogramming the chimeric antigen receptor T cell epigenome to augment anti-tumor activity
重编程嵌合抗原受体 T 细胞表观基因组以增强抗肿瘤活性
  • 批准号:
    10356856
  • 财政年份:
    2021
  • 资助金额:
    $ 8.85万
  • 项目类别:
Maternal Immunization and Determinants of Infant Immunity
母亲免疫接种和婴儿免疫的决定因素
  • 批准号:
    10203486
  • 财政年份:
    2021
  • 资助金额:
    $ 8.85万
  • 项目类别:
Maternal Immunization and Determinants of Infant Immunity
母亲免疫接种和婴儿免疫的决定因素
  • 批准号:
    10616542
  • 财政年份:
    2021
  • 资助金额:
    $ 8.85万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了